Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Augmenting the Efficacy of Benzodiazepine Taper With Telehealth-Delivered Cognitive Behavioral Therapy for Anxiety Disorders in Patients Using Prescription Opioids

NCT05573906 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT05573906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05573906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Augmenting the Efficacy of Benzodiazepine Taper With Telehealth-Delivered Cognitive Behavioral Therapy for Anxiety Disorders in Patients Using Prescription Opioids
Lead sponsor
University of California, Los Angeles
Phase
Not applicable
Overall status
Completed
Start date
April 13, 2023
Completion date
July 31, 2025
Enrollment
42 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorders